Big Move For Aardvark Therapeutics Inc.
Mon, Apr 28, 2025 at 07:50 PM
Aardvark Therapeutics Inc. (AARD:NASDAQ) rocketted at $10.12, a gain of 27.6%. On Mon, Apr 28, 2025, AARD:NASDAQ touched a New 2-Week High of $10.12. The stock got featured on our News Catalysts scanner on Fri, Apr 04, 2025 at 03:18 PM in the 'EARNINGS' category. From Mon, Apr 14, 2025, the stock recorded 55.56% Up Days and 60.00% Green Days
About Aardvark Therapeutics Inc. (AARD:NASDAQ)
Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic...
Top 10 Gainers:
- Movella Holdings Inc Com (MVLA:NASDAQ), 861.54%
- AGM Group Holdings Inc. (AGMH:NASDAQ), 175.72%
- LogicMark Inc Com Par$ (New) (LGMK:NASDAQ), 48.28%
- Pony AI Inc. (PONY:NASDAQ), 47.22%
- Universe Pharmaceuticals Inc (UPC:NASDAQ), 40.33%
- JIADE LIMITED (JDZG:NASDAQ), 36.57%
- Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ), 35.54%
- Aardvark Therapeutics Inc. (AARD:NASDAQ), 27.62%
- Portage Biotech Inc. (PRTG:NASDAQ), 27.46%
- Wag! Group Co. (PET:NASDAQ), 26.69%